A pioneer in Nanotechnology, Fluorotronics Inc. is the first company to introduce and license a patented Carbon-Fluorine Spectroscopy platform technology for molecular detection, measurement and imaging of compounds, materials or molecules. This disruptive technology utilizes a family of pulsed laser-based PLIRFA™ devices to non-invasively detect carbon-fluorine (C-F) bonds and taggants across the entire fluoroorganic industry.
Fluorotronics provides efficient, integrated and cost-effective solutions that address the product lifecycle in Nanotechnology, Pharmaceutical and Life Science markets. Fluorotronics is a development stage California C corporation headquartered in San Diego, California with regional operations in Moscow, Russia.
The following is the list of scholars from Fluorotronics, Inc. who currently serve as editors for one or more SciTechnol journals.
The following is the list of scholars from Fluorotronics, Inc. who published one or more articles in SciTechnol journals.
The following is the list of articles by scholars from Fluorotronics, Inc. that are published in SciTechnol journals.
Microvascular effect after the application of cell therapy with a concentrate of hematopoietic stem cells in patients with peripheral arterial disease with non-critical limb ischemia and diabetesResearch Article: J Regen Med 2020, 9:3
Lauro Fabián Amador Medina1 *, Blanca Olivia Murillo Ortíz1 , Luis Carlos Padierna García2 , Carlos Villaseñor Mora2 , Enrique Castro Camus3 , Goretti Hernández Cardoso3 and Juan Manuel Malacara Hernández 4
Adipose Derived Stem Cell Engraftment Improves Erectile Function in a Rat Model of Cavernosal Nerve InjuryResearch Article: J Regen Med 2020, 9:3
James E. Anaissie1 , Amit G. Reddy1 , Bryant Song2 , Zahra Brabadi3 , Nora M. Haney4, Fatemeh Daneshimehr3 , Travis Chen2 , Kevin Swan2 , Kenneth J. DeLay5 , Laith Alzweri5 , Philip Kadowitz2 , Bysani Chandrasekar6,7 , Eckhard U. Alt3 , Wayne J.G. Hellstrom4 and Reza Izadpanah3
- Commentary: J Regen Med 2020, 9:3
Clinical outcomes and safety of a combined autologous bone marrow concentrate intraosseous and intraarticular injection for knee osteoarthritis at 12 monthsResearch Article: J Regen Med 2020, 9:3
M. Sheinkop1*, M. Langhenry1, D. Curran-Everett3, and T. T. Sand4
Comparison of Vitronectin and Fibronectin as Substrates during the Culture of Human Embryonic Stem CellsShort Communication: J Regen Med 2020, 9:3